[1]
M. Andabaka, Šarlota Mesaroš, N. Veselinović, O. Tamaš, M. Budimkić, and P. J. Drulovic, “NEUROMYELITIS OPTICA SPECTRUM DISORDERS: THERAPEUTIC CONSIDERATIONS: NMOSD therapeutic considerations”, medi, vol. 58, no. 1, Feb. 2025, doi: 10.5937/medi58-55665.